SCHEMBL29464441

SCHEMBL29464441

Cc1ccccc1-c1cccc(NS(=O)(=O)c2cccc(N3CCC[C@@](C)(C(=O)O)C3)n2)n1

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KIF18A Q8NI77 8/20 0.35
DGAT1 O75907 1/20 0.34
KCNH2 Q12809 1/20 0.34
CNR1 P21554 3/20 0.33
SMYD2 Q9NRG4 1/20 0.33
KMO O15229 2/20 0.32
JAK2 O60674 1/20 0.32
HSD11B1 P28845 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP11B2 P19099 1/20 0.32
SYK P43405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19951369 1.00 KIF18A (0.35) KIF18ADGAT1KCNH2CNR1SMYD2
SCHEMBL19951367 1.00 KIF18A (0.35) KIF18ADGAT1KCNH2CNR1SMYD2
SCHEMBL19925396 0.89 KIF18A (0.33) KIF18ADGAT1KCNH2KMOJAK2
SCHEMBL19925398 0.89 KIF18A (0.33) KIF18ADGAT1KCNH2KMOJAK2
SCHEMBL29464342 0.89 KIF18A (0.33) KIF18ADGAT1KCNH2KMOJAK2
SCHEMBL19927751 0.89 CHRNA7 (0.37) KIF18ADGAT1KCNH2CNR1HSD11B1
SCHEMBL29464332 0.89 CHRNA7 (0.37) KIF18ADGAT1KCNH2CNR1HSD11B1
SCHEMBL19927754 0.89 CHRNA7 (0.37) KIF18ADGAT1KCNH2CNR1HSD11B1
SCHEMBL19951305 0.87 DGAT1 (0.34) KIF18ADGAT1KCNH2KMOJAK2
SCHEMBL19951306 0.87 DGAT1 (0.34) KIF18ADGAT1KCNH2KMOJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641873-B N- (pyridin-2-yl) pyridine-sulfonamide derivatives and their use for the treatment of disease 诺华股份有限公司 2022-03-18 CN claimed
CN-109641873-B N- (pyridin-2-yl) pyridine-sulfonamide derivatives and their use for the treatment of disease 诺华股份有限公司 2022-03-18 CN disclosed